AdvisorShares Investments’s NRX Pharmaceuticals NRXP Stock Holding History

AdvisorShares Investments’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$896K	Buy	420,467 +92,463	+28%	+$187K	0.16%	90
2025 Q4	$889K	Sell	328,004 -14,132	-4%	-$37.9K	0.15%	83
2025 Q3	$1.13M	Buy	342,136 +78,339	+30%	+$224K	0.18%	62
2025 Q2	$860K	Sell	263,797 -23,000	-8%	-$57.6K	0.16%	76
2025 Q1	$556K	Sell	286,797 -23,517	-8%	-$66.3K	0.11%	93
2024 Q4	$683K	Buy	310,314 +180,229	+139%	+$242K	0.13%	69
2024 Q3	$220K	Buy	130,085 +22,000	+20%	+$44.3K	0.04%	212
2024 Q2	$279K	Buy	108,085 +46,606	+76%	+$166K	0.05%	204
2024 Q1	$290K	Sell	61,479 -2,784	-4%	-$12.8K	0.05%	215
2023 Q4	$296K	Buy	+64,263	New	+$212K	0.07%	208

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

AdvisorShares Investments's NRXP Position: Q1 2026 in Review

AdvisorShares Investments increased its NRX Pharmaceuticals (NRXP) stake by 28% in Q1 2026, buying an estimated $187K and bringing the position to 420,467 shares worth $896K. The position accounts for 0.16% of the portfolio, ranked #90.

AdvisorShares Investments first reported a position in NRXP in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.13M in Q3 2025. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

AdvisorShares Investments held 420,467 shares of NRX Pharmaceuticals worth $896K as of Q1 2026.
AdvisorShares Investments bought 92,463 NRX Pharmaceuticals shares in Q1 2026, an estimated $187K.
NRX Pharmaceuticals made up 0.16% of AdvisorShares Investments's portfolio in Q1 2026, its #90 holding.
AdvisorShares Investments first reported a position in NRX Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
AdvisorShares Investments's NRX Pharmaceuticals position peaked at $1.13M in Q3 2025.
33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.